Affordable Access

BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes.

Authors
  • Mitsudo, S M
  • Greenwald, E S
  • Banerji, B
  • Koss, L G
Type
Published Article
Journal
Cancer
Publication Date
Aug 15, 1984
Volume
54
Issue
4
Pages
751–755
Identifiers
PMID: 6744207
Source
Medline
License
Unknown

Abstract

The occurrence of pulmonary disease associated with long-term BCNU therapy is reported in two patients treated for astrocytoma grade II whose clinical presentations of pulmonary complications and corresponding tissue alterations showed striking differences. One patient presented with a dramatic, fulminating, and rapidly fatal pulmonary disease. His lungs revealed atypical proliferation of pneumocytes, moderate interstitial inflammation, fibrosis and intra-alveolar hyalin membranes. The second patient presented with slowly progressive dyspnea, ultimately leading to death secondary to severe diffuse alveolar septal fibrosis. Individual differences in response to toxicity are suggested and discussed.

Report this publication

Statistics

Seen <100 times